# Sarepta Therapeutics Inc – FDA Inspection, Mar 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/sarepta-therapeutics-inc/f2328570-0fa3-42c6-be66-01a192cca9cc
Source feed: FDA_Inspections

> FDA inspection 1200687 of Sarepta Therapeutics Inc, March 24, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200687
- Company Name: Sarepta Therapeutics Inc
- Inspection Date: 2023-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Center: Biologics
- Office Name: New England District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1277727 - 2025-07-15

## Related Officers

- [Company Rep](https://www.keypedia.com/people/emmanuel-adu-gyamfi/50f014f0-f8d5-4b21-9cb0-0fdcf785edb5)
- [FDA Associated Person](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [Company Rep](https://www.keypedia.com/people/sukyoung-sohn/f3ab72eb-f212-4603-9625-c5740cf56980)

Company: https://www.keypedia.com/companies/sarepta-therapeutics-inc/5a8d2168-ec04-4530-a81f-00bab06c4a44

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
